US Patent Issued to ANNOVIS BIO on March 24 for "Inhibition of neurological injuries due to infections via administration of Butanetap and analogs thereof" (Pennsylvania Inventor)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,582,632, issued on March 24, was assigned to ANNOVIS BIO INC. (Berwyn, Pa.).

"Inhibition of neurological injuries due to infections via administration of Butanetap and analogs thereof" was invented by Maria Maccecchini (West Chester, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to methods of inhibiting or treating neurological damage in a human who is infected by or at risk of infection by a virus, a bacterium, a fungus, a protozoan or a parasite that can cause neurological damage, comprising administering to a human a compound selected from the group consisting of Formula (I), Formula (II), Formula (III) or Formula (IV) or ...